Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer Q3 earnings beat does little for the battered share price
08:13am, Tuesday, 31'st Oct 2023
A smaller-than-expected third-quarter loss from Pfizer Inc (NYSE:PFE) was not enough to move the stock pre-market as it revealed the scars from a tail-off in demand from Covid treatments. Disclosing w
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
07:51am, Tuesday, 31'st Oct 2023
CNBC's Joe Kernen reports on the company's quarterly earnings results.
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
07:03am, Tuesday, 31'st Oct 2023
The results come two weeks after Pfizer slashed its full-year adjusted earnings and revenue guidance and launched a sweeping $3.5 billion cost-cutting plan.
Pfizer swings to quarterly loss due to Paxlovid write-off
06:49am, Tuesday, 31'st Oct 2023
Pfizer on Tuesday reported its first quarterly loss since 2019, as the U.S. drugmaker recorded $5.6 billion in charges related to its COVID products like its antiviral treatment Paxlovid and vaccine C
7 Low-Risk Stock Picks to Double Your Money
03:39pm, Monday, 30'th Oct 2023
Risk and reward have an inverse relationship. It's one of the guiding principles of investing in stocks and any other asset.
Busy Week for Earnings, Fed, Reports; MCD, ON Beat in Q3
12:03pm, Monday, 30'th Oct 2023
Mid-October near-term highs have given way to lower trading levels for the most part in the past couple weeks.
Pfizer's (PFE) Key Drugs to Drive Q3 Earnings Amid COVID Decline?
10:33am, Monday, 30'th Oct 2023
Pfizer (PFE) expects better non-COVID operational revenue growth sequentially in the third quarter, driven by its key products, new launches as well as newly acquired products.
Pfizer RSV vaccine lags GSK's as head-to-head competition underway
06:35am, Monday, 30'th Oct 2023
Pfizer , which dominated COVID vaccine sales, now finds itself looking up at GSK , whose rival new respiratory syncytial virus (RSV) vaccine has surged to an early lead since the shots launched this s
The 7 Most Undervalued Long-Term Stocks to Buy: October 2023
05:21pm, Sunday, 29'th Oct 2023
As I type this, equity investors can relate to the statement “nowhere to run, nowhere to hide.” The tech-heavy NASDAQ index is down over 4% in the five days ending Oct. 26.
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
08:45am, Saturday, 28'th Oct 2023
Roche spent $7.1 billion on a company, primarily because of an IBD therapy. Pfizer just got approval for a pill to treat ulcerative colitis.
The 7 Most Undervalued Dividend Stocks to Buy: October 2023
06:05am, Friday, 27'th Oct 2023
Historically, the last quarter of the year has been good for equities. However, the markets seem to have started Q4 on a nervous note.
Pfizer's combination flu and COVID vaccine candidates effective, trial data shows
02:45pm, Thursday, 26'th Oct 2023
Shares of Pfizer Inc (NYSE:PFE) and its German partner BioNTech rose after the two companies announced positive results from a Phase 1/2 study evaluating their combination vaccine candidates for COV
Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive data
08:10am, Thursday, 26'th Oct 2023
Pfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.
Pfizer and BioNTech announce positive data in early trial of flu/COVID combination vaccine
07:00am, Thursday, 26'th Oct 2023
Pfizer Inc. PFE and German partner BioNTEch SE BNTX announced positive results from a Phase 1/2 trial of their combined mRNA flu/COVID vaccine on Thursday in adults aged 18 to 64. The vaccine candidat
Pfizer, BioNtech say flu-COVID shot generates immune response
06:53am, Thursday, 26'th Oct 2023
Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against the virus strains in early- to mid-stage trials.
